{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:18:27Z","timestamp":1792657107658,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s13555-015-0068-3","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T14:37:51Z","timestamp":1421764671000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review"],"prefix":"10.1007","volume":"5","author":[{"given":"Arnd","family":"Jacobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"issue":"Suppl 1","key":"68_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2230.2012.04337.x","volume":"37","author":"SN Cohen","year":"2012","unstructured":"Cohen SN, Baron SE, Archer CB. Guidance on the diagnosis and clinical management of psoriasis. Clin Exp Dermatol. 2012;37(Suppl 1):13\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"68_CR2","first-page":"1","volume":"13","author":"KM Cordoro","year":"2008","unstructured":"Cordoro KM. Topical therapy for the management of childhood psoriasis: part I. Skin Therapy Lett. 2008;13:1\u20133.","journal-title":"Skin Therapy Lett"},{"key":"68_CR3","first-page":"855","volume":"12","author":"KL Akamine","year":"2013","unstructured":"Akamine KL, Gustafson CJ, Yentzer BA, et al. A double-blind, randomized clinical trial of 20% alpha\/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis. J Drugs Dermatol. 2013;12:855\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"957\u201362","key":"68_CR4","first-page":"964","volume":"59","author":"DG Federman","year":"1999","unstructured":"Federman DG, Froelich CW, Kirsner RS. Topical psoriasis therapy. Am Fam Physician. 1999;59(957\u201362):964.","journal-title":"Am Fam Physician"},{"key":"68_CR5","first-page":"815","volume":"9","author":"M Sticherling","year":"2011","unstructured":"Sticherling M, Augustin M, Boehncke W, et al. Therapy of psoriasis in childhood and adolescence\u2014a German expert consensus. J Dtsch Dermatol Ges. 2011;9:815\u201323.","journal-title":"J Dtsch Dermatol Ges"},{"key":"68_CR6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0025-6196(11)62116-2","volume":"76","author":"PM Witman","year":"2001","unstructured":"Witman PM. Topical therapies for localized psoriasis. Mayo Clin Proc. 2001;76:943\u20139.","journal-title":"Mayo Clin Proc"},{"key":"68_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","volume":"61","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section\u00a04. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61:451\u201385.","journal-title":"J Am Acad Dermatol"},{"key":"68_CR8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjd.12276","volume":"168","author":"EJ Samarasekera","year":"2013","unstructured":"Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168:954\u201367.","journal-title":"Br J Dermatol"},{"key":"68_CR9","unstructured":"Naldi L, Rzany B. Psoriasis (chronic plaque). Clin Evid (Online). 2009; pii: 1706."},{"key":"68_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-012-1214-8","volume":"304","author":"A Nast","year":"2012","unstructured":"Nast A, Boehncke WH, Mrowietz U, et al. German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res. 2012;304:87\u2013113.","journal-title":"Arch Dermatol Res"},{"key":"68_CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09546630410023566","volume":"15","author":"M Pauporte","year":"2004","unstructured":"Pauporte M, Maibach H, Lowe N, et al. Fluocinoloneacetonide topical oil for scalp psoriasis. J Dermatolog Treat. 2004;15:360\u20134.","journal-title":"J Dermatolog Treat"},{"key":"68_CR12","first-page":"771","volume":"4","author":"M Lod\u00e9n","year":"2003","unstructured":"Lod\u00e9n M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J ClinDermatol. 2003;4:771\u201388.","journal-title":"Am J ClinDermatol"},{"key":"68_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1586\/edm.12.18","volume":"7","author":"A Chiricozzi","year":"2012","unstructured":"Chiricozzi A, Chimenti S. Effective topical agents and emerging perspectives in the treatment of psoriasis. Expert Rev Dermatol. 2012;7:283\u201393.","journal-title":"Expert Rev Dermatol"},{"issue":"Suppl 2","key":"68_CR14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.07919.x","volume":"10","author":"A Nast","year":"2012","unstructured":"Nast A, Boehncke W, Mrowietz U, et al. S3\u2014guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges. 2012;10(Suppl 2):S1\u201395.","journal-title":"J Dtsch Dermatol Ges"},{"key":"68_CR15","first-page":"156","volume":"15","author":"B Birgin","year":"2005","unstructured":"Birgin B, Fetil E, Ilknur T, TahsinG\u00fcne\u015f A, Ozkan S. Effects of topical petrolatum and salicylic acid upon skin photoreaction to UVA. Eur J Dermatol. 2005;15:156\u20138.","journal-title":"Eur J Dermatol"},{"key":"68_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/CCID.S9042","volume":"3","author":"A Kornhauser","year":"2010","unstructured":"Kornhauser A, Coelho SG, Hearing VJ. Applications of hydroxy acids: classification, mechanisms and photoactivity. Clin Cosmet Investig Dermatol. 2010;3:135\u201342.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"68_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000329026","volume":"222","author":"M Augustin","year":"2011","unstructured":"Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011;222:363\u201374.","journal-title":"Dermatology"},{"key":"68_CR18","first-page":"103","volume":"144","author":"MA Kinney","year":"2009","unstructured":"Kinney MA, Feldman SR. What\u2019s new in the management of psoriasis? G Ital Dermatol Venereol. 2009;144:103\u201317.","journal-title":"G Ital Dermatol Venereol"},{"key":"68_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.141.1.43","volume":"141","author":"CL Carroll","year":"2005","unstructured":"Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol. 2005;141:43\u20136.","journal-title":"Arch Dermatol"},{"key":"68_CR20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.12968\/bjon.2008.17.5.28823","volume":"17","author":"S Ryan","year":"2008","unstructured":"Ryan S. Psoriasis: characteristics, psychosocial effects and treatment options. Br J Nurs. 2008;17:284\u201390.","journal-title":"Br J Nurs"},{"key":"68_CR21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.clindermatol.2008.01.015","volume":"26","author":"JW Fluhr","year":"2008","unstructured":"Fluhr JW, Cavallotti C, Berardesca E. Emollients, moisturizers and keratolytic agents in psoriasis. Clin Dermatol. 2008;26:380\u20136.","journal-title":"Clin Dermatol"},{"key":"68_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-4362.1999.00500.x","volume":"38","author":"M Lebwohl","year":"1999","unstructured":"Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol. 1999;38:16\u201324.","journal-title":"Int J Dermatol"},{"key":"68_CR23","doi-asserted-by":"crossref","unstructured":"Finlay A. Emollients as adjuvant therapy for psoriasis. J Dermatol Treat. 1997:25\u201327.","DOI":"10.3109\/09546639709160944"},{"key":"68_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1468-3083.2012.04640.x","volume":"27","author":"AGM Hendriks","year":"2013","unstructured":"Hendriks AGM, Keijsers RRMC, de Jong EMGJ, Seyger MMB, van de Kerkhof PCM. Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2013;27:399\u2013410.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"68_CR25","unstructured":"Childhood psoriasis: often favorable outcome. Prescrire Int. 2009;18:275."},{"key":"68_CR26","first-page":"227","volume":"18","author":"A Dawn","year":"2006","unstructured":"Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs. 2006;18:227\u201333.","journal-title":"Dermatol Nurs"},{"key":"68_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013005268","volume":"30","author":"AS Raut","year":"2013","unstructured":"Raut AS, Prabhu RH, Patravale VB. Psoriasis clinical implications and treatment: a review. Crit Rev Ther Drug Carrier Syst. 2013;30:183\u2013216.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"27\u201330","key":"68_CR28","first-page":"3","volume":"257","author":"MJ Tidman","year":"2013","unstructured":"Tidman MJ. Improving outcomes in patients with psoriasis. Practitioner. 2013;257(27\u201330):3.","journal-title":"Practitioner"},{"key":"68_CR29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2340\/00015555-70474477","volume":"70","author":"B Berne","year":"1990","unstructured":"Berne B, Blom I, Sp\u00e5ngberg S. Enhanced response of psoriasis to UVB therapy after pretreatment with a lubricating base. A single-blind controlled study. Acta Derm Venereol. 1990;70:474\u20137.","journal-title":"Acta Derm Venereol"},{"key":"68_CR30","doi-asserted-by":"crossref","unstructured":"Boyvat A, Erdi H, Birol A, Gurgey E. Interaction of commonly used emollients with photochemotherapy. Photodermatol Photoimmunol Photomed. 2000;16:156\u201360.","DOI":"10.1034\/j.1600-0781.2000.160402.x"},{"key":"68_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2340\/00015555713740","volume":"71","author":"B Kristensen","year":"1991","unstructured":"Kristensen B, Kristensen O. Topical salicylic acid interferes with UVB therapy for psoriasis. Acta Derm Venereol. 1991;71:37\u201340.","journal-title":"Acta Derm Venereol"},{"key":"68_CR32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0190-9622(95)90071-3","volume":"32","author":"M Lebwohl","year":"1995","unstructured":"Lebwohl M, Martinez J, Weber P, DeLuca R. Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy. J Am Acad Dermatol. 1995;32:469\u201371.","journal-title":"J Am Acad Dermatol"},{"key":"68_CR33","first-page":"311","volume":"85","author":"Duijnhoven van","year":"2005","unstructured":"van Duijnhoven, Mirella WFM, Hagenberg R, et al. Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis. Acta Derm Venereol. 2005;85:311\u20137.","journal-title":"Acta Derm Venereol"},{"key":"68_CR34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.2005.01773.x","volume":"30","author":"JH Rim","year":"2005","unstructured":"Rim JH, Jo SJ, Park JY, Park BD, Youn JI. Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients. Clin Exp Dermatol. 2005;30:409\u201313.","journal-title":"Clin Exp Dermatol"},{"key":"68_CR35","first-page":"4","volume":"66","author":"EA Tanghetti","year":"2000","unstructured":"Tanghetti EA. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and\/or corticosteroid. Cutis. 2000;66:4\u201311.","journal-title":"Cutis"},{"key":"68_CR36","first-page":"383","volume":"50","author":"KL Watsky","year":"1992","unstructured":"Watsky KL, Freije L, Leneveu MC, Wenck HA, Leffell DJ. Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis. 1992;50:383\u20136.","journal-title":"Cutis"},{"key":"68_CR37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2133.1995.tb02693.x","volume":"133","author":"S Singh","year":"1995","unstructured":"Singh S, Gopal J, Mishra RN, Pandey SS. Topical 0.05% betamethasone dipropionate: efficacy in psoriasis with once a day vs. twice a day application. Br J Dermatol. 1995;133:497\u20138.","journal-title":"Br J Dermatol"},{"key":"68_CR38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2340\/0001555576353356","volume":"76","author":"I Hagemann","year":"1996","unstructured":"Hagemann I, Proksch E. Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol. 1996;76:353\u20136.","journal-title":"Acta Derm Venereol"},{"key":"68_CR39","first-page":"20392","volume":"19","author":"M Pan","year":"2013","unstructured":"Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatol Online J. 2013;19:20392.","journal-title":"Dermatol Online J"},{"key":"68_CR40","first-page":"797","volume":"37","author":"L Gip","year":"1985","unstructured":"Gip L, Lundberg M. A double-blind controlled trial of a new antipsoriatic cream containing urea and sodium chloride. CurrTher Res. 1985;37:797\u2013804.","journal-title":"CurrTher Res"},{"key":"68_CR41","first-page":"805","volume":"37","author":"T Fredriksson","year":"1985","unstructured":"Fredriksson T, Lundberg M. A blind controlled comparison between a new cream (\u201c12\u00a0+\u00a012\u201d), its vehicle and salicylic acid in petrolatum on psoriatic plaques. Curr Ther Res. 1985;37:805\u20139.","journal-title":"Curr Ther Res"},{"issue":"1","key":"68_CR42","first-page":"1","volume":"7","author":"PK Lakshmi","year":"2011","unstructured":"Lakshmi PK, Bhaskaran S. Phase II study of topical niosomal urea gel-an adjuvant in the treatment of psoriasis. Int J Pharm Sci Rev Res. 2011;7(1):1\u20137.","journal-title":"Int J Pharm Sci Rev Res"},{"key":"68_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1721727X0500300108","volume":"3","author":"GA Vena","year":"2005","unstructured":"Vena GA, Cassano N, Agnusdei CP, et al. Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea-based emollients. Eur J Inflamm. 2005;3:37\u201341.","journal-title":"Eur J Inflamm"},{"key":"68_CR44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-4362.2000.00986-3.x","volume":"39","author":"A Shemer","year":"2000","unstructured":"Shemer A, Nathansohn N, Kaplan B, Weiss G, Newman N, Trau H. Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole. Int J Dermatol. 2000;39:532\u20134.","journal-title":"Int J Dermatol"},{"key":"68_CR45","first-page":"650","volume":"171","author":"KM Taube","year":"1985","unstructured":"Taube KM, Fiedler H, Wohlrab W, Wozniak KD. Untersuchungen zur Kurzzeitbehandlung der Psoriasis vulgaris mit Dithranol unter Harnstoffzusatz. Dermatol Monatsschr. 1985;171:650\u20133.","journal-title":"Dermatol Monatsschr"},{"key":"68_CR46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/030006058301100208","volume":"11","author":"J Koo","year":"1983","unstructured":"Koo J, Cuffie CA, Tanner DJ, et al. Mometasonefuroate 0.1%-salicylic acid 5% ointment one-17,21-dipropionate in the treatment of erythematous squamous dermatoses. J Int Med Res. 1983;11:108\u201312.","journal-title":"J Int Med Res"},{"key":"68_CR47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2230.1998.00361.x","volume":"23","author":"E Berardesca","year":"1998","unstructured":"Berardesca E, PieroVignoli G, Distante E, Rona C. Effects of glycolic acid on psoriasis. Clin Exp Dermatol. 1998;23:190\u20131.","journal-title":"Clin Exp Dermatol"},{"key":"68_CR48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-3083.2000.00006.x","volume":"14","author":"K Kostarelos","year":"2000","unstructured":"Kostarelos K, Teknetzis A, Lefaki I, Ioannides D, Minas A. Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis. J Eur Acad Dermatol Venereol. 2000;14:5\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"68_CR49","doi-asserted-by":"crossref","unstructured":"Chan CS, Van Voorhees, Abby S, et al. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60:962\u201371.","DOI":"10.1016\/j.jaad.2008.11.890"},{"key":"68_CR50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0140-6736(90)90183-6","volume":"335","author":"NH Cox","year":"1990","unstructured":"Cox NH, Sharpe G. Emollients, salicylic acid and ultraviolet erythema. Lancet. 1990;335:53\u20134.","journal-title":"Lancet"},{"key":"68_CR51","first-page":"154","volume":"12","author":"E Fetil","year":"2002","unstructured":"Fetil E, Ozka S, Soyal MC, Ilknur T, Erdem Y, G\u00fcne\u015f AT. Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB. Eur J Dermatol. 2002;12:154\u20136.","journal-title":"Eur J Dermatol"},{"key":"68_CR52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajhp\/57.7.645","volume":"57","author":"BP Peters","year":"2000","unstructured":"Peters BP, Weissman FG, Gill MA. Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm. 2000;57:645\u201359.","journal-title":"Am J Health Syst Pharm"},{"key":"68_CR53","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1468-3083.2009.03372.x","volume":"23","author":"J Ortonne","year":"2009","unstructured":"Ortonne J, Chimenti S, Luger T, Puig L, Reid F, Tr\u00fceb RM. Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol. 2009;23:1435\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"68_CR54","first-page":"270","volume":"10","author":"L Kircik","year":"2011","unstructured":"Kircik L. Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis. J Drugs Dermatol. 2011;10:270\u20133.","journal-title":"J Drugs Dermatol"},{"key":"68_CR55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2230.1986.tb00457.x","volume":"11","author":"SM Going","year":"1986","unstructured":"Going SM, Guyer BM, Jarvie DR, Hunter JA. Salicylic acid gel for scalp psoriasis. Clin Exp Dermatol. 1986;11:260\u20132.","journal-title":"Clin Exp Dermatol"},{"key":"68_CR56","first-page":"1679","volume":"101","author":"S Nolting","year":"1983","unstructured":"Nolting S, Hagemeier HH. Therapie erythrosquam\u00f6ser Dermatosen. Betamethason-Dipropionat plus Salizyls\u00e4ure im Vergleich zu Betamethason-Dipropionat-L\u00f6sung. Fortschr Med. 1983;101:1679\u201383.","journal-title":"Fortschr Med"},{"key":"68_CR57","first-page":"459","volume":"34","author":"R Elie","year":"1983","unstructured":"Elie R, Durocher LP, Kavalec EC. Effect of salicylic acid on the activity of betamethas. Curr Ther Res. 1983;34:459\u201368.","journal-title":"Curr Ther Res"},{"key":"68_CR58","doi-asserted-by":"crossref","unstructured":"Tiplica G, Salavastru CM. Mometasonefuroate 0.1% and salicylic acid 5% vs. mometasonefuroate 0.1% as sequential local therapy in psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23:905\u201312.","DOI":"10.1111\/j.1468-3083.2009.03214.x"},{"key":"68_CR59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09546639809160546","volume":"9","author":"H Katz","year":"1998","unstructured":"Katz H, Tanner D, Cuffie CA, et al. A comparison of the efficacy and safety of the combination mometasonefuroate 0.1%\/salicylic acid 5% ointment with each of its components in psoriasis. J Dermatolog Treat. 1998;9:151\u20136.","journal-title":"J Dermatolog Treat"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-015-0068-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T05:25:51Z","timestamp":1690867551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-015-0068-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s13555-015-0068-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}